These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12224511)

  • 1. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
    Dantuma NP; Heessen S; Lindsten K; Jellne M; Masucci MG
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8381-5. PubMed ID: 10890896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.
    Tellam J; Sherritt M; Thomson S; Tellam R; Moss DJ; Burrows SR; Wiertz E; Khanna R
    J Biol Chem; 2001 Sep; 276(36):33353-60. PubMed ID: 11435434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
    Lee SP; Brooks JM; Al-Jarrah H; Thomas WA; Haigh TA; Taylor GS; Humme S; Schepers A; Hammerschmidt W; Yates JL; Rickinson AB; Blake NW
    J Exp Med; 2004 May; 199(10):1409-20. PubMed ID: 15148339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.
    Zhang M; Coffino P
    J Biol Chem; 2004 Mar; 279(10):8635-41. PubMed ID: 14688254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
    J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Moss DJ; Kurilla MG; Cooper L
    Int Immunol; 1997 Oct; 9(10):1537-43. PubMed ID: 9352359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.
    Sharipo A; Imreh M; Leonchiks A; Brändén C; Masucci MG
    FEBS Lett; 2001 Jun; 499(1-2):137-42. PubMed ID: 11418128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.
    Dantuma NP; Masucci MG
    Semin Cancer Biol; 2003 Feb; 13(1):69-76. PubMed ID: 12507558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.
    Lautscham G; Rickinson A; Blake N
    Microbes Infect; 2003 Apr; 5(4):291-9. PubMed ID: 12706442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
    Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
    PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.
    Leonchiks A; Stavropoulou V; Sharipo A; Masucci MG
    FEBS Lett; 2002 Jul; 522(1-3):93-8. PubMed ID: 12095625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology. Hide and seek in the peptidome.
    Yewdell JW
    Science; 2003 Sep; 301(5638):1334-5. PubMed ID: 12958347
    [No Abstract]   [Full Text] [Related]  

  • 17. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
    Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci MG
    Nat Med; 1998 Aug; 4(8):939-44. PubMed ID: 9701247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.
    Tellam J; Connolly G; Green KJ; Miles JJ; Moss DJ; Burrows SR; Khanna R
    J Exp Med; 2004 May; 199(10):1421-31. PubMed ID: 15148340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.